CYBERDYNE, INC. (hereinafter “the Company”), together with its strategic partner in Türkiye, Diagenics, held a meeting on October 13, 2026, in Ankara, the capital of the Republic of Türkiye, with Prof. Dr. Kemal Memişoğlu, Minister of Health, and Assoc. Prof. Şuayıp Birinci, Deputy Minister of Health. The meeting focused on strategic cooperation in advanced medicine, healthcare, AI and robotics through the application of HCPS Cybernics with Physical AI technology.
During the meeting, the participants exchanged views on promoting the deployment and social implementation of Cybernics technology in Türkiye, which fuses bio/medical systems with AI/robotics/information systems. Discussions also addressed the potential establishment of an international hub that would comprehensively advance medical and healthcare services, clinical research, research and development, and human resource development.
Specifically, the discussions explored opportunities for cooperation in deploying and implementing the Company’s broad range of Cybernics technologies, including Cybernics Treatment using the Wearable Cyborg HAL, designed to promote improvement and restoration of neuromuscular functions; Cyvis, which enables the continuous collection, analysis and AI processing of medical and healthcare data in daily life; Acoustic X, an LED-based photoacoustic imaging system that enables high-resolution, non-invasive visualization of peripheral blood vessels and blood conditions without the use of contrast agents; the Cybernic Master Remote Robot, which enables collaboration between humans and AI robots; and other advanced AI robotics technologies.
In particular, the participants engaged in in-depth discussions on the potential applications of these Cybernics technologies in addressing cardiovascular diseases, cerebrovascular diseases and diabetes, with a focus on prevention, early detection, treatment, post-treatment management and daily health management.
The Ministry of Health of Türkiye responded positively to the proposed initiative, and the participants discussed moving forward with an assessment of its practical feasibility through collaboration with relevant organizations and institutions.
The Company has been advancing initiatives to promote the adoption of Cybernics technology and develop business partnerships in Türkiye, including the international event “Cybernicx Future 2026,” held in Istanbul in January 2026. The meeting represented an important opportunity to expand these efforts into discussions with government authorities and to further advance concrete business development initiatives in advanced medicine and healthcare in Türkiye.
Going forward, the Company will strengthen collaboration with its strategic partner Diagenics, as well as government agencies, medical institutions, universities and research organizations in Türkiye. Through these partnerships, the Company aims to promote the wider adoption of Cybernics Treatment, clinical applications of advanced medical technologies, joint research and human resource development, while advancing the broader social implementation of AI and robotics technologies.
Furthermore, the Company aims to develop Türkiye into one of the international hubs for medicine, healthcare, AI and robotics powered by Cybernics technology. Through the social implementation of innovative technologies, CYBERDYNE will continue contributing to the resolution of global societal challenges and the creation of new industries.
